From: Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis
Characteristics | Univariable analysis | ||
---|---|---|---|
OR | 95% CI | p-value | |
Age | 1.308 | 0.97–1.111 | 0.285 |
Sex (male) | 0.667 | 0.078–5.678 | 0.711 |
Time to diagnosis | 1.031 | 0.966–1.1 | 0.365 |
General conditions | |||
Shock | 5 | 0.551–45.391 | 0.153 |
Pneumonia | 2.222 | 0.245–20.174 | 0.478 |
Intubation | 3.667 | 0.354–38.029 | 0.276 |
ICU required | 3.667 | 0.354–38.029 | 0.276 |
Immunocompromised | 897,486,006 | 0 | 0.999 |
Underlying diseases | |||
Diabetes mellitus | 0 | 0 | 1 |
Hypertension | 0.4 | 0.034–4.681 | 0.465 |
Autoimmune | 1.375 | 0.096–19.643 | 0.814 |
Acute kidney injury | 1.375 | 0.096–19.643 | 0.814 |
Chronic kidney disease | 1.75 | 0.215–14.224 | 0.601 |
End stage renal disease | 0.563 | 0.047–6.769 | 0.65 |
Malignancy | 9 | 0.748–108.31 | 0.083 |
Transplantation | 0 | 0 | 0.999 |
Steroid | 1.75 | 0.215–14.224 | 0.601 |
Chemotherapy | 3 | 0.15–59.89 | 0.472 |
Radiotherapy | 18 | 1.194–271.461 | 0.037* |
Laboratory data | |||
WBC count | 1 | 1 | 0.39 |
Hemoglobin | 0.76 | 0.496–1.163 | 0.206 |
Platelet | 0.994 | 0.983–1.006 | 0.362 |
Creatinine | 1.046 | 0.665–1.645 | 0.845 |
ALT | 0.966 | 0.885–1.053 | 0.432 |
Albumin | 0.202 | 0.017–2.39 | 0.205 |
C-reactive protein | 1.028 | 1.001–1.057 | 0.045* |
Clinical symptoms | |||
Fever | 1.5 | 0.176–12.775 | 0.711 |
Abdominal pain | 4.667 | 0.404–53.95 | 0.217 |
Vomiting | 8.25 | 0.795–85.564 | 0.077 |
Diarrhea | 0.778 | 0.096–6.322 | 0.814 |
Abdominal fullness | 2.222 | 0.245–20.174 | 0.478 |
GI bleeding | 1.778 | 0.148–21.395 | 0.65 |
Endoscopic features | |||
Ulcer | 1.778 | 0.148–21.395 | 0.65 |
Inflammation | 3 | 0.15–59.89 | 0.472 |
Polypoid lesion | 0 | 0 | 0.999 |
Duodenum | 1.375 | 0.096–19.643 | 0.814 |
Jejunum | 5,250,293,239 | 0 | 1 |
Ileum | 0.273 | 0.026–2.829 | 0.276 |
Antiviral treatment | 2.5 | 0.214–29.254 | 0.465 |